NewAmsterdam Pharma (NAMS) EBT Margin (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted EBT Margin of -1732.91% for Q2 2026, down 1642.21 percentage points from -90.70% a year earlier and down 139.46 percentage points from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) EBT Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at NewAmsterdam Pharma was -3644.21%, down 3385.30 percentage points year-over-year; for FY2025, it was -905.74%, down 375.49 percentage points from FY2024.
- Annual EBT Margin shows a three-year change of -883.70 percentage points (FY2022 to FY2025).
- In prior years, NewAmsterdam Pharma's EBT Margin was -530.25% in FY2024 (+725.32 pp), -1255.57% in FY2023 (-1233.53 pp) and -22.04% in FY2022.
- Quarterly EBT Margin has run from a low of -234134.38% in Q4 2025 to a high of -57.19% in Q3 2024 over five years.
- On a year-over-year basis, EBT Margin has declined in each of the last four quarters, with an average year-over-year change of -30248.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2024, with a gain of 5438.69 percentage points; the weakest was Q4 2025, with a drop of 233412.66 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -1593.45% (Q1 2026), -234134.38% (Q4 2025) and -20691.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | -1,732.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,732.91% |
| Mar 31, 2026 | -1,593.45% |
| Dec 31, 2025 | -234,134.38% |
| Sep 30, 2025 | -20,691.09% |
| Jun 30, 2025 | -90.70% |
| Mar 31, 2025 | -1,327.30% |
| Dec 31, 2024 | -721.71% |
| Sep 30, 2024 | -57.19% |
| Jun 30, 2024 | -1,711.58% |
| Mar 31, 2024 | -6,692.86% |
| Dec 31, 2023 | -6,160.40% |
| Sep 30, 2023 | -1,602.62% |
| Jun 30, 2023 | -2,230.11% |
| Mar 31, 2023 | -486.94% |
API Access
NewAmsterdam Pharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();